The Biotechnology Industry Organization’s annual BIO-CEO conference on Feb. 23-24 is featuring an RNAi discussion panel this year featuring six top industry exectives.
Sirna Therapeutics’ president and CEO Howard Robin is set to present, as is Alnylam Pharmaceuticals’ president and CEO John Maraganore.
Additional panel participants include CytRx president and CEO Steven Kriegsman, Nucleonics president and CEO Bob Towarnicki, Intradigm chairman and CEO John Spears, and Acuity Pharmaceuticals president and CEO Dale Pfost.
Representatives for Acuity also noted that the company’s co-founder and senior director of research Sam Reich is scheduled to take part in an ophthalmology discussion panel during the conference.